Table 2.
Group A (n = 480) | Group B (n = 1570) | p Value | |
---|---|---|---|
Age | 73.88 ± 8.87 | 69.79 ± 12.11 | <0.0001 |
Years of smoking | 44.03 ± 10.96 | 41.98 ± 13.45 | 0.241 |
Years without smoking | 17.08 ± 11.62 | 16.34 ± 12.83 | 0.608 |
Cigarettes per diem | 21.11 ± 15.27 | 20.23 ± 12.57 | 0.478 |
Number of previous TURBT | 0.53 ± 1.17 | 0.32 ± 1.02 | <0.0001 |
Number of total TURBT | 2.27 ± 1.64 | 2.18 ± 1.68 | 0.310 |
Sex | |||
Male | 431 (89.8) | 1299 (82.7) | <0.0001 |
Female | 49 (10.2) | 271 (17.3) | <0.0001 |
Smoker | |||
Yes | 120 (25.7) | 456 (29.4) | <0.0001 |
No | 100 (21.4) | 477 (30.8) | <0.0001 |
Ex | 247 (52.9) | 618 (39.8) | <0.0001 |
Diabetes | 157 (32.8) | 302 (19.2) | <0.0001 |
Hypertension | 353 (73.7) | 873 (55.6) | <0.0001 |
Dyslipidemia | 148 (34.4) | 282 (18) | <0.0001 |
COPD | 99 (20.7) | 173 (11) | <0.0001 |
Chronic kidney disease | 51 (10.7) | 92 (5.9) | <0.0001 |
Hepatitis C virus | 17 (3.6) | 36 (2.3) | 0.126 |
Other cancers | 72 (18.8) | 254 (22.6) | 0.117 |
Prostate cancer | 15 (4.5) | 62 (7.8) | 0.47 |
Kidney cancer | 11 (3.3) | 20 (2.5) | 0.462 |
Upper tract urinary cancer | 7 (2.1) | 27 (3.4) | 0.245 |
Recurrent tumor | 21 (9.3) | 109 (10.4) | 0.622 |
Bladder cancer | 368 (76.7) | 1270 (80.9) | 0.048 |
Grading | |||
G1 | 68 (14.5) | 265 (17.2) | 0.024 |
G2 | 82 (17.4) | 343 (22.2) | 0.024 |
G3 | 218 (46.4) | 661 (42.8) | 0.024 |
Staging | |||
pTa | 187 (41.5) | 768 (50.5) | 0.005 |
pT1 | 119 (26.4) | 306 (20.1) | 0.005 |
pT2 | 56 (12.4) | 186 (12.2) | 0.005 |
pT4 | 2 (0.4) | 2 (0.1) | 0.005 |
Multifocal | 144 (34.1) | 400 (29.7) | 0.085 |
Concomitant CIS | 22 (5.4) | 42 (3.5) | 0.087 |
MIBC | 58 (12.5) | 188 (12.3) | 0.438 |
Treatment | |||
MMC | 39 (8.4) | 113 (7.7) | 0.764 |
BCG | 68 (14.4) | 187 (12.7) | 0.764 |
Cystectomy | 11 (2.4) | 39 (2.6) | 0.764 |
Re-TURBT | 28 (6.1) | 87 (5.9) | 0.764 |